Wayland Group Corp.

OTC: MRRCF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Oakville, ONReports USD

#765 of 1,394 Healthcare companies by revenue28th-percentile growth

EA Score

——

FH —DQ —GM —SS 49

v0.1 · 5/100 weight · pillars only

↑ listing tenure, balance-sheet leverage · ↓ market scale, disclosure history

Methodology →

Revenue TTM

$2.5M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$51.6M

Employees

Market cap

$2.1k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$2.5M$2.5M2017

Net income-$51.6M-$51.6M2017

Operating income-$21.3M-$21.3M2017

Total assets$74.5M$74.5M2017

Liabilities$25.4M$25.4M2017

Equity$49.1M$49.1M2017

Revenue trend

FY2015 – FY2017 · USD

FY15

$3.1M

FY16

$2.5M

FY17

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Wayland Group Corp. booked $2.5M in FY2017 revenue, contracting 19% year over year — slower than 72% of Healthcare companies we track, at a -2079.4% net margin.

Peers · Healthcare

CanaQuest Medical Corp.——Viveve Medical, Inc.——ForU Holdings, Inc.——Green Growth Brands Inc.——

Key facts

CEODavid Miller

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersOakville, ON

ExchangeOTC: MRRCF

Employees68

IPO date2001-05-07

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.